Suppliers / Centrient Pharmaceuticals Netherlands

Centrient Pharmaceuticals Netherlands

Netherlands Updated 9 July 2026

Centrient Pharmaceuticals Netherlands is an API manufacturer based in Netherlands. It holds 7 active US drug master files across a filed portfolio of 6 molecules.

7
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Amoxicillin US FDA 2
Atorvastatin US FDA 1
Cefadroxil US FDA 1
Cephalexin US FDA 1
Nystatin US FDA 1
Rosuvastatin US FDA 1

Also appears on these molecule pages

Questions about Centrient Pharmaceuticals Netherlands

Does Centrient Pharmaceuticals Netherlands hold a US DMF or a CEP?
Centrient Pharmaceuticals Netherlands holds 7 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Centrient Pharmaceuticals Netherlands make?
6 molecules are on record against Centrient Pharmaceuticals Netherlands, including Amoxicillin, Atorvastatin, Cefadroxil and Cephalexin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Centrient Pharmaceuticals Netherlands comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability